The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Is C-Reactive Protein Specific for Vascular Disease in Women?

Nader Rifai, PhD; Julie E. Buring, ScD; I-Min Lee, MBBS, ScD; JoAnn E. Manson, MD; and Paul M Ridker, MD
[+] Article, Author, and Disclosure Information

From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Disclosure: Dr. Ridker is named as a co-inventor on patents related to the use of inflammatory biomarkers in cardiovascular disease.

Grant Support: By the National Heart, Lung, and Blood Institute (HL 58755); an Established Investigator Award from the American Heart Association (Dr. Ridker); and a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation (Dr. Ridker).

Requests for Single Reprints: Paul M Ridker, MD, Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215; e-mail, pridker@partners.org.

Current Author Addresses: Dr. Rifai: Department of Laboratory Medicine, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115.

Drs. Buring, Lee, Manson, and Ridker: Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215.

Author Contributions: Conception and design: N. Rifai, P.M. Ridker.

Analysis and interpretation of the data: N. Rifai, J.E. Manson, P.M. Ridker.

Drafting of the article: N. Rifai, P.M. Ridker.

Critical revision of the article for important intellectual content: N. Rifai, J.E. Buring, I.-M. Lee, J.E. Manson, P.M. Ridker.

Final approval of the article: N. Rifai, J.E. Buring, I.-M. Lee, J.E. Manson, P.M. Ridker.

Provision of study materials or patients: J.E. Buring, P.M. Ridker.

Statistical expertise: J.E. Manson, P.M. Ridker.

Obtaining of funding: P.M. Ridker.

Administrative, technical, or logistic support: J.E. Buring, J.E. Manson.

Collection and assembly of data: N. Rifai, I.-M. Lee, P.M. Ridker.

Ann Intern Med. 2002;136(7):529-533. doi:10.7326/0003-4819-136-7-200204020-00010
Text Size: A A A

Background: C-reactive protein (CRP) predicts risk for future cardiovascular events in asymptomatic individuals. However, because CRP also predicts total mortality, its specificity for vascular disease is uncertain.

Objective: To compare the predictive value of CRP for cancer and cardiovascular disease, the major determinants of mortality.

Design: Prospective, nested case–control study.

Setting: The Women's Health Study, an ongoing prospective cohort study involving 28 345 U.S. women 45 years of age and older who were healthy at the time of enrollment.

Participants: 643 women who subsequently developed cancer or had cardiovascular events; 643 age- and smoking-matched women who remained free of either disease during 58-month follow-up.

Measurements: Baseline CRP levels.

Results: Little evidence showed that increasing quartiles of baseline CRP predicted incident cancer (adjusted relative risks, 1.0, 1.2, 1.1, and 1.3; P for trend > 0.2). In contrast, increasing quartiles of baseline CRP were a strong marker of risk for future cardiovascular disease (adjusted relative risks, 1.0, 2.9, 3.4, and 5.6; P for trend < 0.001).

Conclusion: C-reactive protein appears to independently predict cardiovascular events but not cancer.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Is C-Reactive Protein Specific for Vascular Disease in Women?

The summary below is from the full report titled “Is C-Reactive Protein Specific for Vascular Disease in Women?” It is in the 2 April 2002 issue of Annals of Internal Medicine (volume 136, pages 529-533). The authors are N Rifai, JE Buring, I-M Lee, JE Manson, and PM Ridker. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.


Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.